The Oncology Institute, Inc. (TOI) Stock Overview
Explore The Oncology Institute, Inc.’s financial performance, market position, analyst ratings, and future outlook.
The Oncology Institute, Inc. (TOI)
Key Financials
Key Financials
Market Cap
512.9M
P/E Ratio
-18.32
EPS (TTM)
$-0.36
ROE
2.10%
TOI Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of The Oncology Institute, Inc. (NASDAQ: TOI) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, The Oncology Institute, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of TOI on the NASDAQ shows an RSI of 63.78, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $5.88 for the NASDAQ listing.
Key metrics behind The Oncology Institute, Inc.'s NASDAQ-traded stock include a P/E ratio of -18.32 and a market capitalization of 512.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of TOI on the NASDAQ.